Lixte Biotechnology H -CW25LIXTWPreferred / convertible
13F holders, Q2 2025 (June 30)4holders +1
1new positions
0sold out
1famous investor
$0.03avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Lixte Biotechnology H -CW25 (LIXTW) in their 13F filings, up 1 from Q1 2025. 1 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($722), Clear Street LLC ($648) and NFSG Corp ($72). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Lixte Biotechnology H -CW25
- CUSIP
- 539319111
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $72 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 2,500 shares bought and 801 shares sold, net +1,699 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Citadel Advisors | — | Reduce -3.1% | 25,231 | $722 |
| Clear Street LLC | — | No change | 22,654 | $648 |
| NFSG Corp | — | New | 2,500 | $72 |
| Bank of America Corp. | — | No change | 100 | $3 |
"% of holder's portfolio" is LIXTW's weight in each manager's 13F, not the share of Lixte Biotechnology H -CW25 the manager owns.